Market Cap 168.20B
Revenue (ttm) 44.56B
Net Income (ttm) 6.70B
EPS (ttm) N/A
PE Ratio 20.08
Forward PE 18.70
Profit Margin 15.05%
Debt to Equity Ratio 0.77
Volume 2,485,292
Avg Vol 2,156,930
Day's Range N/A - N/A
Shares Out 371.62M
Stochastic %K 34%
Beta 0.88
Analysts Strong Sell
Price Target $617.91

Company Profile

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; d...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 781 622 1000
Address:
168 Third Avenue, Waltham, United States
Following_the_trend
Following_the_trend Jul. 2 at 4:06 PM
$TMO Winner here.
0 · Reply
FutureCapitall
FutureCapitall Jul. 2 at 3:21 PM
$ARCT announced a strategic collaboration with $TMO to support the development of ARCT-032 for cystic fibrosis, leveraging Thermo Fisher’s integrated drug development platform spanning manufacturing, clinical research, and commercial readiness. The partnership is designed to streamline the transition from late-stage clinical development into potential commercialization, with Thermo Fisher providing end-to-end operational support while Arcturus continues to lead the program. From a market perspective, this type of collaboration is typically viewed as an execution and de-risking step, strengthening development infrastructure rather than changing the underlying clinical or regulatory thesis.
0 · Reply
Dr_Feel_Good
Dr_Feel_Good Jul. 2 at 1:58 PM
$ARCT fantastic news re: $TMO collaboration to help advance Stage 3 development of ARCT-032. Hope everyone is having a great Thursday so far. Im hoping we can maintain momentum and break into double digits soon.
0 · Reply
notreload_ai
notreload_ai Jul. 2 at 12:43 PM
$ARCT partners with $TMO to advance ARCT-032, its investigational mRNA therapy for cystic fibrosis, into Phase 3. https://notreload.xyz/xy/arcturus-surges-on-thermo-fisher-cystic-fibrosis-deal/
0 · Reply
MarketLegendd
MarketLegendd Jun. 29 at 7:54 PM
Market is pricing in some hesitation for $TMO after the latest dip, currently hovering around 505. I’m patient here—not forcing any entries until I see a clearer base formation on the tape.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 29 at 3:20 PM
$TMO These stocks go up 2 or 2x in a month just need to catch it Now you will have to wait for Earnings
0 · Reply
NasdaqFrontier
NasdaqFrontier Jun. 29 at 2:25 PM
TMO is under pressure, trading near 503. The $TMO valuation is getting compressed, but the core business stays strong. Just waiting for the dust to settle on this dip.
0 · Reply
Simp_Slayer
Simp_Slayer Jun. 25 at 8:27 PM
$TMO what's up w this dinosaur 🦕
0 · Reply
Following_the_trend
Following_the_trend Jun. 24 at 1:57 PM
$TMO Nice move. Hope it holds
0 · Reply
StockConsultant
StockConsultant Jun. 24 at 3:23 AM
$TMO Thermo Fisher Scientific stock watch, pullback to 467.25 triple+ support area with bullish indicators at https://stockconsultant.com/?TMO Long Trade Target 1: 507.35 Profit: 8.1% Stop/Trailing Stop: 458.18 Loss: 2.4% P/L ratio: 3.4 : 1 - Good Target 2: 520.49 Profit: 10.9% P/L ratio: 4.5 : 1 - Excellent Extreme rally BULLISH [Positioning] Intermediate trend bullish, Downtrend turned sideways, possible bottom. [Positioning] at support [Timing] Strong bullish 3 day candlestick pattern with Strong 3 day accumulation. BEARISH None
0 · Reply
Latest News on TMO
Thermo Fisher resumed with a Market Perform at Bernstein

2026-06-26T10:30:45.000Z - 8 days ago

Thermo Fisher resumed with a Market Perform at Bernstein


Thermo Fisher initiated with a Neutral at Piper Sandler

2026-06-11T09:57:04.000Z - 23 days ago

Thermo Fisher initiated with a Neutral at Piper Sandler


Thermo Fisher downgraded to Hold from Buy at HSBC

2026-06-03T09:21:41.000Z - 4 weeks ago

Thermo Fisher downgraded to Hold from Buy at HSBC


Thermo Fisher assumed with an Outperform at Wolfe Research

2026-06-01T21:13:51.000Z - 4 weeks ago

Thermo Fisher assumed with an Outperform at Wolfe Research


Thermo Fisher Scientific Announces Quarterly Dividend

May 20, 2026, 5:00 PM EDT - 6 weeks ago

Thermo Fisher Scientific Announces Quarterly Dividend


Thermo Fisher Scientific Transcript: AGM 2026

May 20, 2026, 1:00 PM EDT - 6 weeks ago

Thermo Fisher Scientific Transcript: AGM 2026


Thermo Fisher Scientific Slides: FY 2026

May 20, 2026, 1:00 PM EDT - 6 weeks ago

Thermo Fisher Scientific Slides: FY 2026


Thermo Fisher Scientific Transcript: Investor Day 2026

May 20, 2026, 9:00 AM EDT - 6 weeks ago

Thermo Fisher Scientific Transcript: Investor Day 2026


Thermo Fisher Scientific Slides: FY 2026

May 20, 2026, 9:00 AM EDT - 6 weeks ago

Thermo Fisher Scientific Slides: FY 2026


Thermo Fisher resumed with a Sector Perform at RBC Capital

2026-05-14T20:52:36.000Z - 7 weeks ago

Thermo Fisher resumed with a Sector Perform at RBC Capital


Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle

May 11, 2026, 8:30 AM EDT - 7 weeks ago

Nalgene Outdoor Introduces Fresh Flow™ Straw Bottle


Thermo Fisher Scientific Proxy statement: Proxy filing

May 11, 2026, 8:00 AM EDT - 7 weeks ago

Thermo Fisher Scientific Proxy statement: Proxy filing


Thermo Fisher Scientific to Host Investor Day

Apr 28, 2026, 8:00 AM EDT - 2 months ago

Thermo Fisher Scientific to Host Investor Day


Thermo Fisher to Sell Microbiology Business to Astorg

Apr 27, 2026, 9:09 AM EDT - 2 months ago

Thermo Fisher to Sell Microbiology Business to Astorg


Thermo Fisher price target lowered to $600 from $700 at Stifel

2026-04-24T12:18:08.000Z - 2 months ago

Thermo Fisher price target lowered to $600 from $700 at Stifel


Thermo Fisher Scientific Earnings Call Transcript: Q1 2026

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Thermo Fisher Scientific Earnings Call Transcript: Q1 2026


Thermo Fisher Scientific Earnings release: Q1 2026

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Thermo Fisher Scientific Earnings release: Q1 2026


Thermo Fisher Scientific Quarterly report: Q1 2026

Apr 23, 2026, 8:30 AM EDT - 2 months ago

Thermo Fisher Scientific Quarterly report: Q1 2026


Thermo Fisher Scientific Reports First Quarter 2026 Results

Apr 23, 2026, 6:00 AM EDT - 2 months ago

Thermo Fisher Scientific Reports First Quarter 2026 Results


Thermo Fisher Scientific Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 3 months ago

Thermo Fisher Scientific Proxy statement: Proxy filing


Thermo Fisher Scientific Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 3 months ago

Thermo Fisher Scientific Proxy statement: Proxy filing


Thermo Fisher Scientific Increases Quarterly Dividend

Feb 25, 2026, 4:15 PM EST - 4 months ago

Thermo Fisher Scientific Increases Quarterly Dividend


5 Oversold Stocks to Buy Before They Rebound

Feb 23, 2026, 10:59 AM EST - 4 months ago

5 Oversold Stocks to Buy Before They Rebound

AMZN LPLA MSFT PANW


Thermo Fisher Scientific Earnings Call Transcript: Q4 2025

Jan 29, 2026, 8:30 AM EST - 5 months ago

Thermo Fisher Scientific Earnings Call Transcript: Q4 2025


Thermo Fisher Scientific Annual report: Q4 2025

Jan 29, 2026, 8:30 AM EST - 5 months ago

Thermo Fisher Scientific Annual report: Q4 2025


Thermo Fisher Scientific Annual report: Q4 2025

Jan 29, 2026, 8:30 AM EST - 5 months ago

Thermo Fisher Scientific Annual report: Q4 2025


Thermo Fisher Scientific Earnings release: Q4 2025

Jan 29, 2026, 8:30 AM EST - 5 months ago

Thermo Fisher Scientific Earnings release: Q4 2025


Josh Brown's ‘best stocks in the market': Health Care

Nov 24, 2025, 1:50 PM EST - 7 months ago

Josh Brown's ‘best stocks in the market': Health Care

A LLY MTD XLV


Following_the_trend
Following_the_trend Jul. 2 at 4:06 PM
$TMO Winner here.
0 · Reply
FutureCapitall
FutureCapitall Jul. 2 at 3:21 PM
$ARCT announced a strategic collaboration with $TMO to support the development of ARCT-032 for cystic fibrosis, leveraging Thermo Fisher’s integrated drug development platform spanning manufacturing, clinical research, and commercial readiness. The partnership is designed to streamline the transition from late-stage clinical development into potential commercialization, with Thermo Fisher providing end-to-end operational support while Arcturus continues to lead the program. From a market perspective, this type of collaboration is typically viewed as an execution and de-risking step, strengthening development infrastructure rather than changing the underlying clinical or regulatory thesis.
0 · Reply
Dr_Feel_Good
Dr_Feel_Good Jul. 2 at 1:58 PM
$ARCT fantastic news re: $TMO collaboration to help advance Stage 3 development of ARCT-032. Hope everyone is having a great Thursday so far. Im hoping we can maintain momentum and break into double digits soon.
0 · Reply
notreload_ai
notreload_ai Jul. 2 at 12:43 PM
$ARCT partners with $TMO to advance ARCT-032, its investigational mRNA therapy for cystic fibrosis, into Phase 3. https://notreload.xyz/xy/arcturus-surges-on-thermo-fisher-cystic-fibrosis-deal/
0 · Reply
MarketLegendd
MarketLegendd Jun. 29 at 7:54 PM
Market is pricing in some hesitation for $TMO after the latest dip, currently hovering around 505. I’m patient here—not forcing any entries until I see a clearer base formation on the tape.
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 29 at 3:20 PM
$TMO These stocks go up 2 or 2x in a month just need to catch it Now you will have to wait for Earnings
0 · Reply
NasdaqFrontier
NasdaqFrontier Jun. 29 at 2:25 PM
TMO is under pressure, trading near 503. The $TMO valuation is getting compressed, but the core business stays strong. Just waiting for the dust to settle on this dip.
0 · Reply
Simp_Slayer
Simp_Slayer Jun. 25 at 8:27 PM
$TMO what's up w this dinosaur 🦕
0 · Reply
Following_the_trend
Following_the_trend Jun. 24 at 1:57 PM
$TMO Nice move. Hope it holds
0 · Reply
StockConsultant
StockConsultant Jun. 24 at 3:23 AM
$TMO Thermo Fisher Scientific stock watch, pullback to 467.25 triple+ support area with bullish indicators at https://stockconsultant.com/?TMO Long Trade Target 1: 507.35 Profit: 8.1% Stop/Trailing Stop: 458.18 Loss: 2.4% P/L ratio: 3.4 : 1 - Good Target 2: 520.49 Profit: 10.9% P/L ratio: 4.5 : 1 - Excellent Extreme rally BULLISH [Positioning] Intermediate trend bullish, Downtrend turned sideways, possible bottom. [Positioning] at support [Timing] Strong bullish 3 day candlestick pattern with Strong 3 day accumulation. BEARISH None
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 23 at 5:05 AM
$TMO Share Price: $464.04 Contract Selected: Jul 17, 2026 $460 Calls Buy Zone: $12.26 – $15.14 Target Zone: $21.38 – $26.13 Potential Upside: 65% ROI Time to Expiration: 24 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 22 at 7:43 PM
$TMO Current Stock Price: $463.70 Contracts to trade: $462.5 TMO Jun 26 2026 Call Entry: $6.60 Exit: $11.89 ROI: 80% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Jun. 18 at 8:23 PM
$TMO Share Price: $464.55 Contract Selected: Jul 10, 2026 $465 Calls Buy Zone: $12.41 – $15.33 Target Zone: $20.90 – $25.55 Potential Upside: 59% ROI Time to Expiration: 21 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
TeamSetupAlpha
TeamSetupAlpha Jun. 16 at 3:15 PM
When that big pullback happened after our historic run-up, retail was panicking about a "double top" failure. But inside our small trading circle, we called it for what it was: a healthy retest of previous resistance turned support. We didn’t short; we aggressively re-entered at the exact bottom of that June dip. Boom. Up 132% YTD today. Stop trading alone in the dark. $PG $TMO $LIN $ABBV
0 · Reply
ShadowBanningIsBad
ShadowBanningIsBad Jun. 16 at 2:03 PM
$ASTS WOW this is so wrong first there are 3 versions of starlink V2 did direct to cell data, phone, sms via $TMO V3 is larger and will do direct to cell broad band for carriers or Starlink Frequencies. ASTS Block 2 can do direct to cell high speed but maybe 100 per sat so 240 sats would handle 24k high speed connections at once. $ASTS currently has 1 Block 2 Sat. $SPCX has never delivered a Block 2 Sat to orbit and No one has delivered 3 Block 2 Sats to orbit. $SPCX can do emergency/ Remote direct to cell SMS and phone and data right now for the entire planet if the local governments allowed it.
1 · Reply
RunnerSignals
RunnerSignals Jun. 11 at 8:20 PM
$BKH $PFE $DTIL $PIPR $TMO Wall Street Analyst Upgrades to Watch https://stocksrunner.com/news/2026-06-11-wall-street-analyst-upgrades-to-watch
0 · Reply
RunnerSignals
RunnerSignals Jun. 11 at 8:19 PM
$INTC $HOOD $GD $TMO $DAKT led today's upgrade flow. intel traded 154m shares on a rare double upgrade, while hood added 6.8% on above-average volume. defense and industrial names continued attracting institutional bids https://stocksrunner.com/news/2026-06-11-wall-street-analyst-upgrades-to-watch
0 · Reply
ThotBroker
ThotBroker Jun. 9 at 9:10 PM
0 · Reply
peloswing
peloswing Jun. 7 at 3:53 PM
$TMO Strong support at $456.5 & knocking on a Breakout! Average 12 Month Price-Target: $602.5 (+27.4% from current levels)
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 3 at 3:37 PM
0 · Reply
YouOnlyLiveTwice
YouOnlyLiveTwice Jun. 3 at 1:40 PM
$TMO $460 next…. These med device stocks are done for another 12-18 months
1 · Reply